Bright Peak Therapeutics

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

Health and bio

TIMELINE · MONEY RAISED

Bright Peak Therapeutics | 491 days from website to first raise on record

Raised $125M in 2 sourced rounds·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

1. August 17, 2026
   Series B+ · amount undisclosed
   Source: fundraisingfox.com
2. June 11, 2024
   Series B+ · $90M
   JJohnson & Johnson Innovation (lead), AAlexandria Venture Investments, FFidelity, IInvus, KKB Investment, NNorthleaf Capital Partners, QQatar Investment Authority, RRA Capital Management, VVenrock, VVersant Ventures
   Source: venturelab.swiss
3. July 28, 2020
   Series A · $35M
   VVersant Ventures (lead)
   Source: bioworld.com
4. March 25, 2019
   Website created

Founders and team

• JB
  Jeffrey Bode Founder
• VP
  Vijaya Pattabiraman Founder
• FW
  Fred Wiklund President & CEO
• BK
  Bertolt Kreft Chief Scientific Officer

Investors

• AAlexandria Venture Investments
• FFidelity
• IInvus
• JJohnson & Johnson Innovationlead investor
• KKB Investment
• NNorthleaf Capital Partners
• QQatar Investment Authority
• RRA Capital Management
• VVenrock
• VVersant Ventureslead investor

Companies like Bright Peak Therapeutics

• DDren Bio$350M Series B+ · Oct 2026
• OOutrun TherapeuticsSeed · Apr 2024
• AAsher Bio$55M Series B+ · Apr 2024
• CCoultreon$125M Series A · Apr 2026
• EElixion BiotechPre Seed · May 2026
• HHaptena Therapeutics$3.53M Seed · Dec 2025

Other companies backed by Johnson & Johnson Innovation

• TT-Therapeutics$133M Series B+ · Nov 2026
• TTRIMTECH Therapeutics$14M Seed · Jun 2026
• IIterative Health$77M Series B+ · Apr 2026
• DDistalmotion$150M Series B+ · Nov 2025
• CCitryll$92.5M Series B+ · Dec 2024
• AAccent Therapeutics$75M Series B+ · Jan 2024

Johnson & Johnson Innovation portfolio →